Tillomed Italia SRL . Pharmaceutical Import Profile — Italy (DGFT 2022–2026)

Name: Tillomed Italia SRL . Pharmaceutical Import Records from India — 2 Products, $2.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Tillomed Italia SRL . — Pharmaceutical Importer Profile (2026) | 2 Products, $2.6M Trade | TransData Nexus

Tillomed Italia SRL .

Pharmaceutical Importer · Italy · Immunosuppressants Focus · $2.6M Total Trade · DGFT Verified

Tillomed Italia SRL . is a pharmaceutical importer based in Italy with a total trade value of $2.6M across 2 products in 2 therapeutic categories. Based on 53 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Tillomed Italia SRL . sources from 1 verified Indian supplier, with Emcure Pharmaceuticals Limited accounting for 100.0% of imports.

Tillomed Italia SRL . — Import Portfolio & Supplier Network

Tillomed Italia SRL . import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Tillomed Italia SRL .?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Emcure Pharmaceuticals Limited	$282.6K	20	100.0%

Tillomed Italia SRL . sources from 1 verified Indian supplier across 14 distinct formulations. The sourcing is highly concentrated — Emcure Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Tillomed Italia SRL . Import?

Formulation	Value	Ships
Medicines mycophenolate 250MG 10x10c	$51.2K	3
Medicines combi Pack of melphalan hydrochloride for injection 50 MG/vial (lyophilized) & sterile diluent	$50.0K	2
Medicines combi Pack of carmustinefor injection USP 100 MG/vial (lyophilized) & propylene glycol INJ	$50.0K	2
Medicines busulfan injection 60MG/10ML : batch no. esd25004b, mfg: feb 2025, exp: jan 2027 (packs)	$43.3K	1
Medicines zoledronic acid INJ 4MG/5ML tillo it sn : batch no. es250055b , mfg: feb 2025 , exp: jan	$29.8K	1
Medicines cinacalcet 60mgtab 2x14t	$19.4K	1
Medicines zoledronic acid INJ 4MG/5ML tillo it sn : batch no. es240349a, mfg: dec 2024 exp: nov	$18.4K	1
Medicines cinacalcet 30mgtab 2x14t	$13.9K	1
Medicines busulfan injection 60MG/10ML : batch no. esd25012c, mfg: feb 2025, exp: jan 2027 (packs)	$6.5K	1
(a.e.o. t1 certificate no	$0	1
Medicines (a.e.o. t1 certificate no: inaaace4574c1f224 date: 29.03.2022, valid upto: 28.03.2025)	$0	3
Medicines busulfan injection 60MG/10ML : batch no. esd25004b, mfg: feb 2025, exp: jan 2027 (packs) (foc)	$0	1
(a.e.o. t1 certificate no: inaaace4574c1f224 date: 29.03.2022, validupto: 28.03.2025)	$0	1
Medicines busulfan injection 60MG/10ML : batch no. esd25012c, mfg: feb 2025, exp: jan 2027 (packs)(foc)	$0	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Mycophenolate	Immunosuppressants	$2.5M	51	0.8%	11
2	Carmustine	Advanced Oncology	$100.0K	2	0.4%	9

Tillomed Italia SRL . imports 2 pharmaceutical products across 2 categories into Italy totaling $2.6M.

Tillomed Italia SRL . — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Tillomed Italia Srl is an Italian pharmaceutical company specializing in the importation and distribution of high-quality generic medicines. Established in 2017, the company is headquartered in Milan, Italy, at Viale Giulio Richard 1/A, 20143. It operates under the legal framework of a limited liability company, with a registered capital of €30,000. Tillomed Italia Srl is a subsidiary of Tillomed Laboratories Limited, a UK-based pharmaceutical company that focuses on developing, licensing, and marketing generic pharmaceuticals across various European territories. The parent company has experienced significant growth, expanding from €5 million in sales in 2013 to a €100 million business by 2020.

In Italy, Tillomed Italia Srl plays a crucial role in the pharmaceutical distribution network by importing and supplying generic medicines to meet the country's healthcare needs. The company's product portfolio includes a range of therapeutic areas, with a particular emphasis on immunosuppressants and oncology treatments. By leveraging its affiliation with Tillomed Laboratories Limited, Tillomed Italia Srl ensures access to a diverse range of high-quality generic medicines, contributing to the accessibility and affordability of essential treatments in the Italian market.

2Distribution Network

Tillomed Italia Srl's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across Italy. The company operates from its headquarters in Milan, which serves as the central hub for its logistics operations. While specific details about additional warehouse locations are not publicly disclosed, the centralization in Milan suggests a streamlined distribution process aimed at optimizing supply chain efficiency. The company's logistics capabilities are tailored to meet the demands of the Italian pharmaceutical market, ensuring timely and reliable delivery of imported medicines to various healthcare facilities and pharmacies nationwide.

3Industry Role

In Italy's pharmaceutical supply chain, Tillomed Italia Srl functions primarily as a pharmaceutical importer and distributor. The company imports finished pharmaceutical formulations from its parent company, Tillomed Laboratories Limited, and other suppliers, focusing on generic medicines. By acting as an intermediary between international manufacturers and the Italian market, Tillomed Italia Srl ensures the availability of essential generic medicines, thereby enhancing the accessibility and affordability of healthcare treatments in Italy. The company's role is pivotal in bridging the gap between global pharmaceutical production and local distribution, contributing to the overall efficiency and effectiveness of the Italian healthcare system.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Tillomed Italia SRL .

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Tillomed Italia Srl's sourcing strategy exhibits a high degree of concentration, with a significant portion of its imports originating from a single supplier, Emcure Pharmaceuticals Limited. According to TransData Nexus proprietary trade data, the company has imported approximately $283,000 worth of products from Emcure Pharmaceuticals Limited, accounting for 20 shipments. This concentration indicates a strategic partnership between Tillomed Italia Srl and Emcure Pharmaceuticals Limited, likely aimed at ensuring a consistent supply of high-quality generic medicines.

While this sourcing strategy may offer benefits such as favorable pricing and streamlined logistics, it also presents potential risks associated with supplier dependency. Any disruptions in Emcure Pharmaceuticals Limited's production or supply chain could impact Tillomed Italia Srl's ability to meet market demand. However, the company's diversified product portfolio, encompassing 14 unique formulations across two therapeutic categories, suggests a level of resilience in its sourcing approach. This diversification may mitigate the impact of potential supply chain disruptions by allowing the company to adjust its product offerings in response to changing circumstances.

2Supply Chain Resilience

Tillomed Italia Srl's supply chain resilience is influenced by its sourcing strategy, which is heavily reliant on a single supplier, Emcure Pharmaceuticals Limited. This dependency could pose challenges in the event of production delays, quality issues, or logistical disruptions affecting Emcure Pharmaceuticals Limited. To enhance supply chain resilience, it would be prudent for Tillomed Italia Srl to consider diversifying its supplier base, thereby reducing the risk associated with single-source dependency.

Importing Pharmaceuticals into Italy — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Italy

1Regulatory Authority & Framework

In Italy, the primary regulatory authority overseeing pharmaceutical imports is the Agenzia Italiana del Farmaco (AIFA), the Italian Medicines Agency. AIFA is responsible for ensuring the safety, efficacy, and quality of medicines available in the Italian market. The agency operates under the framework of the Italian Ministry of Health and is guided by European Union regulations and directives, as well as national legislation.

Key legislation governing pharmaceutical imports into Italy includes the Legislative Decree No. 219/2006, which transposes EU Directive 2001/83/EC into Italian law. This decree outlines the procedures for marketing authorization, importation, and distribution of medicinal products. Additionally, the Italian Medicines Agency Act (Law No. 94/1998) establishes the operational framework for AIFA, detailing its responsibilities and functions in regulating pharmaceutical activities within Italy.

For Indian pharmaceutical companies aiming to export to Italy, understanding and complying with AIFA's regulations is essential. This includes obtaining the necessary marketing authorizations, adhering to Good Manufacturing Practice (GMP) standards recognized by the European Union, and ensuring that products meet the quality and safety requirements set forth by AIFA. Engaging with AIFA and staying informed about regulatory updates will facilitate smoother market entry and ongoing compliance for Indian exporters.

2Import Licensing & GMP

Frequently Asked Questions — Tillomed Italia SRL .

What products does Tillomed Italia SRL . import from India?

Tillomed Italia SRL . imports 2 pharmaceutical products across 2 categories. Top imports: Mycophenolate ($2.5M), Carmustine ($100.0K).

Who supplies pharmaceuticals to Tillomed Italia SRL . from India?

Tillomed Italia SRL . sources from 1 verified Indian suppliers. The primary supplier is Emcure Pharmaceuticals Limited (100.0% of imports, $282.6K).

What is Tillomed Italia SRL .'s total pharmaceutical import value?

Tillomed Italia SRL .'s total pharmaceutical import value from India is $2.6M, based on 53 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Tillomed Italia SRL . focus on?

Tillomed Italia SRL . imports across 2 categories. The largest: Immunosuppressants (96.2%), Advanced Oncology (3.8%).

Get Full Tillomed Italia SRL . Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Tillomed Italia SRL .

Tillomed Italia SRL . — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Tillomed Italia SRL .?

What Formulations Does Tillomed Italia SRL . Import?

What Products Does Tillomed Italia SRL . Import?

Top Products by Import Value

Tillomed Italia SRL . Therapeutic Categories — 2 Specializations